MIR205 Gene

HGNC Family Non-coding RNAs
Name microRNA 205
Description microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009]
Summary
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nMiR‐205 is a small non‐coding RNA with multifaceted, context‐dependent functions in cancer. In many epithelial malignancies it acts as a tumor suppressor, helping to preserve epithelial differentiation and counteract epithelial‐to‐mesenchymal transition (EMT). Several studies have shown that reduced miR‐205 levels in non–small cell lung cancer, prostate, breast, melanoma, and glioma are associated with enhanced cell proliferation, migration, invasion and metastasis. Mechanistically, miR‐205 targets a variety of oncogenic mediators – including receptor tyrosine kinases (such as ErbB3), vascular endothelial growth factor A (VEGF‐A), protein kinase Cε, E2F transcription factors, and anti‐apoptotic proteins—that normally drive tumor progression. Its expression is frequently regulated by key transcription factors such as p53 and p63, further linking its loss to EMT induction and aggressive cancer phenotypes."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "20"}]}, {"type": "t", "text": ""}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn addition to its role in tumor initiation and progression, miR‐205 has been implicated in modulating therapeutic responses. In various studies, loss of miR‐205 was linked to resistance to chemotherapy and radiotherapy in cancers such as prostate, pancreatic, and esophageal carcinomas, whereas restoration of miR‐205 expression resensitized tumor cells to drugs like docetaxel, cisplatin, gemcitabine, and even ionizing radiation. These effects are mediated in part by its capacity to impair pro‐survival signaling pathways (for example, the AKT cascade) and autophagy, and by reversing EMT through upregulation of epithelial markers such as E-cadherin. Moreover, miR‐205 expression is subject to epigenetic regulation (including promoter hypermethylation) and can be modulated by microenvironment‐derived stimuli, thereby influencing both intrinsic cell behavior and the circulating miRNA signature used as a non‐invasive diagnostic or prognostic biomarker."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "21", "end_ref": "30"}]}, {"type": "t", "text": ""}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nBeyond its intracellular regulatory circuits, circulating miR‐205 levels have been evaluated as potential biomarkers in several diseases—not only in cancer types such as cervical, bladder, and glioma but also in disorders like Parkinson’s disease and systemic lupus erythematosus. Furthermore, miR‐205 influences additional aspects of tumor biology, including lipid metabolism in hepatocellular carcinoma by targeting metabolic enzymes, and the maintenance of basement membrane integrity in epithelial tissues. Interactions with long non‐coding RNAs (for example, GAS5 and HOTAIR) further exemplify its diverse impact on gene regulatory networks that affect cancer stem cell maintenance and apoptotic responses. Collectively, these findings support the notion that modulation of miR‐205 expression may represent a promising therapeutic avenue as well as serve as a valuable prognostic tool."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "31", "end_ref": "40"}]}, {"type": "t", "text": ""}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Athina Markou, Emily G Tsaroucha, Loukas Kaklamanis, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Prognostic value of mature microRNA-21 and microRNA-205 overexpression in non-small cell lung cancer by quantitative real-time RT-PCR."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Clin Chem (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1373/clinchem.2007.101741"}], "href": "https://doi.org/10.1373/clinchem.2007.101741"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18719201"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18719201"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Jia Yu, David G Ryan, Spiro Getsios, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-184 antagonizes microRNA-205 to maintain SHIP2 levels in epithelia."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Proc Natl Acad Sci U S A (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1073/pnas.0803992105"}], "href": "https://doi.org/10.1073/pnas.0803992105"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19033458"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19033458"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Hailong Wu, Shoumin Zhu, Yin-Yuan Mo "}, {"type": "b", "children": [{"type": "t", "text": "Suppression of cell growth and invasion by miR-205 in breast cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Res (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/cr.2009.18"}], "href": "https://doi.org/10.1038/cr.2009.18"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19238171"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19238171"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Paolo Gandellini, Marco Folini, Nicole Longoni, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-205 Exerts tumor-suppressive functions in human prostate through down-regulation of protein kinase Cepsilon."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Res (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/0008-5472.CAN-08-2894"}], "href": "https://doi.org/10.1158/0008-5472.CAN-08-2894"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19244118"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19244118"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Sotai Kimura, Seiji Naganuma, Dai Susuki, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Expression of microRNAs in squamous cell carcinoma of human head and neck and the esophagus: miR-205 and miR-21 are specific markers for HNSCC and ESCC."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncol Rep (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3892/or_00000804"}], "href": "https://doi.org/10.3892/or_00000804"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20428818"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20428818"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Stephanie B Greene, Jason I Herschkowitz, Jeffrey M Rosen "}, {"type": "b", "children": [{"type": "t", "text": "The ups and downs of miR-205: identifying the roles of miR-205 in mammary gland development and breast cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "RNA Biol (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.4161/rna.7.3.11837"}], "href": "https://doi.org/10.4161/rna.7.3.11837"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20436283"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20436283"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Kayoko Matsushima, Hajime Isomoto, Shigeru Kohno, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNAs and esophageal squamous cell carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Digestion (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1159/000310918"}], "href": "https://doi.org/10.1159/000310918"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20588024"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20588024"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Carmen S Tellez, Daniel E Juri, Kieu Do, et al. "}, {"type": "b", "children": [{"type": "t", "text": "EMT and stem cell-like properties associated with miR-205 and miR-200 epigenetic silencing are early manifestations during carcinogen-induced transformation of human lung epithelial cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Res (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/0008-5472.CAN-10-3035"}], "href": "https://doi.org/10.1158/0008-5472.CAN-10-3035"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21363915"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21363915"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "N Bhatnagar, X Li, S K R Padi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Downregulation of miR-205 and miR-31 confers resistance to chemotherapy-induced apoptosis in prostate cancer cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Death Dis (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/cddis.2010.85"}], "href": "https://doi.org/10.1038/cddis.2010.85"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21368878"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21368878"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Altaf A Dar, Shahana Majid, David de Semir, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miRNA-205 suppresses melanoma cell proliferation and induces senescence via regulation of E2F1 protein."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M111.227611"}], "href": "https://doi.org/10.1074/jbc.M111.227611"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21454583"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21454583"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Xiao Yue, Peiguo Wang, Jun Xu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-205 functions as a tumor suppressor in human glioblastoma cells by targeting VEGF-A."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncol Rep (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3892/or.2011.1588"}], "href": "https://doi.org/10.3892/or.2011.1588"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22159356"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22159356"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Y Xu, T Brenn, E R S Brown, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Differential expression of microRNAs during melanoma progression: miR-200c, miR-205 and miR-211 are downregulated in melanoma and act as tumour suppressors."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Br J Cancer (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/bjc.2011.568"}], "href": "https://doi.org/10.1038/bjc.2011.568"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22223089"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22223089"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "P Gandellini, V Profumo, A Casamichele, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-205 regulates basement membrane deposition in human prostate: implications for cancer development."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Death Differ (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/cdd.2012.56"}], "href": "https://doi.org/10.1038/cdd.2012.56"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22555458"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22555458"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Claudia Piovan, Dario Palmieri, Gianpiero Di Leva, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Oncosuppressive role of p53-induced miR-205 in triple negative breast cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Oncol (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.molonc.2012.03.003"}], "href": "https://doi.org/10.1016/j.molonc.2012.03.003"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22578566"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22578566"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Han-Bo Le, Wang-Yu Zhu, Dong-Dong Chen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Evaluation of dynamic change of serum miR-21 and miR-24 in pre- and post-operative lung carcinoma patients."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Med Oncol (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s12032-012-0303-z"}], "href": "https://doi.org/10.1007/s12032-012-0303-z"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22782668"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22782668"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Shiyo Muratsu-Ikeda, Masaomi Nangaku, Yoichiro Ikeda, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Downregulation of miR-205 modulates cell susceptibility to oxidative and endoplasmic reticulum stresses in renal tubular cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0041462"}], "href": "https://doi.org/10.1371/journal.pone.0041462"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22859986"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22859986"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Vijay Alla, Bhavani S Kowtharapu, David Engelmann, et al. "}, {"type": "b", "children": [{"type": "t", "text": "E2F1 confers anticancer drug resistance by targeting ABC transporter family members and Bcl-2 via the p73/DNp73-miR-205 circuitry."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Cycle (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.4161/cc.21476"}], "href": "https://doi.org/10.4161/cc.21476"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22871739"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22871739"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Paola Tucci, Massimiliano Agostini, Francesca Grespi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Loss of p63 and its microRNA-205 target results in enhanced cell migration and metastasis in prostate cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Proc Natl Acad Sci U S A (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1073/pnas.1110977109"}], "href": "https://doi.org/10.1073/pnas.1110977109"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22949650"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22949650"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Anna Torres, Kamil Torres, Anna Pesci, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Diagnostic and prognostic significance of miRNA signatures in tissues and plasma of endometrioid endometrial carcinoma patients."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Cancer (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/ijc.27840"}], "href": "https://doi.org/10.1002/ijc.27840"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22987275"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22987275"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "Hyun Jin Cho, Guoxiang Liu, Seok Min Jin, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-205 regulates the expression of Parkinson's disease-related leucine-rich repeat kinase 2 protein."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Hum Mol Genet (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/hmg/dds470"}], "href": "https://doi.org/10.1093/hmg/dds470"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23125283"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23125283"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "Mai N Tran, Woonyoung Choi, Matthew F Wszolek, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The p63 protein isoform ΔNp63α inhibits epithelial-mesenchymal transition in human bladder cancer cells: role of MIR-205."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M112.408104"}], "href": "https://doi.org/10.1074/jbc.M112.408104"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23239884"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23239884"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "Z Hagman, B S Haflidadóttir, J A Ceder, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-205 negatively regulates the androgen receptor and is associated with adverse outcome of prostate cancer patients."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Br J Cancer (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/bjc.2013.131"}], "href": "https://doi.org/10.1038/bjc.2013.131"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23571738"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23571738"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "Akira Watahiki, Robyn J Macfarlane, Martin E Gleave, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Plasma miRNAs as biomarkers to identify patients with castration-resistant metastatic prostate cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Mol Sci (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3390/ijms14047757"}], "href": "https://doi.org/10.3390/ijms14047757"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23574937"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23574937"}]}, {"type": "r", "ref": 24, "children": [{"type": "t", "text": "Berlinda Verdoodt, Matthias Neid, Markus Vogt, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-205, a novel regulator of the anti-apoptotic protein Bcl2, is downregulated in prostate cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Oncol (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3892/ijo.2013.1915"}], "href": "https://doi.org/10.3892/ijo.2013.1915"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23612742"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23612742"}]}, {"type": "r", "ref": 25, "children": [{"type": "t", "text": "Jonathan P Saxe, Mengjie Chen, Hongyu Zhao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Tdrkh is essential for spermatogenesis and participates in primary piRNA biogenesis in the germline."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "EMBO J (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/emboj.2013.121"}], "href": "https://doi.org/10.1038/emboj.2013.121"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23714778"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23714778"}]}, {"type": "r", "ref": 26, "children": [{"type": "t", "text": "Junchao Cai, Lishan Fang, Yongbo Huang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-205 targets PTEN and PHLPP2 to augment AKT signaling and drive malignant phenotypes in non-small cell lung cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Res (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/0008-5472.CAN-13-0297"}], "href": "https://doi.org/10.1158/0008-5472.CAN-13-0297"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23856247"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23856247"}]}, {"type": "r", "ref": 27, "children": [{"type": "t", "text": "Lin Lei, Yaping Huang, Wenrong Gong "}, {"type": "b", "children": [{"type": "t", "text": "miR-205 promotes the growth, metastasis and chemoresistance of NSCLC cells by targeting PTEN."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncol Rep (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3892/or.2013.2755"}], "href": "https://doi.org/10.3892/or.2013.2755"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24084898"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24084898"}]}, {"type": "r", "ref": 28, "children": [{"type": "t", "text": "Kinya Okamoto, Kenichi Miyoshi, Yoshikazu Murawaki "}, {"type": "b", "children": [{"type": "t", "text": "miR-29b, miR-205 and miR-221 enhance chemosensitivity to gemcitabine in HuH28 human cholangiocarcinoma cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0077623"}], "href": "https://doi.org/10.1371/journal.pone.0077623"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24147037"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24147037"}]}, {"type": "r", "ref": 29, "children": [{"type": "t", "text": "Anvesha Srivastava, Helle Goldberger, Alexander Dimtchev, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA profiling in prostate cancer--the diagnostic potential of urinary miR-205 and miR-214."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0076994"}], "href": "https://doi.org/10.1371/journal.pone.0076994"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24167554"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24167554"}]}, {"type": "r", "ref": 30, "children": [{"type": "t", "text": "Hong Zheng, Lina Zhang, Yanrui Zhao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Plasma miRNAs as diagnostic and prognostic biomarkers for ovarian cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0077853"}], "href": "https://doi.org/10.1371/journal.pone.0077853"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24223734"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24223734"}]}, {"type": "r", "ref": 31, "children": [{"type": "t", "text": "Tao Zhang, Junping Zhang, Ming Cui, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Hepatitis B virus X protein inhibits tumor suppressor miR-205 through inducing hypermethylation of miR-205 promoter to enhance carcinogenesis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neoplasia (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1593/neo.131362"}], "href": "https://doi.org/10.1593/neo.131362"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24339740"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24339740"}]}, {"type": "r", "ref": 32, "children": [{"type": "t", "text": "Marzia Pennati, Alessia Lopergolo, Valentina Profumo, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-205 impairs the autophagic flux and enhances cisplatin cytotoxicity in castration-resistant prostate cancer cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Pharmacol (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bcp.2013.12.009"}], "href": "https://doi.org/10.1016/j.bcp.2013.12.009"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24370341"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24370341"}]}, {"type": "r", "ref": 33, "children": [{"type": "t", "text": "Ming Cui, Yue Wang, Baodi Sun, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MiR-205 modulates abnormal lipid metabolism of hepatoma cells via targeting acyl-CoA synthetase long-chain family member 1 (ACSL1) mRNA."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Biophys Res Commun (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbrc.2014.01.051"}], "href": "https://doi.org/10.1016/j.bbrc.2014.01.051"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24462768"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24462768"}]}, {"type": "r", "ref": 34, "children": [{"type": "t", "text": "Chi-Hong Chao, Chao-Ching Chang, Meng-Ju Wu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-205 signaling regulates mammary stem cell fate and tumorigenesis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Clin Invest (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1172/JCI73351"}], "href": "https://doi.org/10.1172/JCI73351"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24911147"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24911147"}]}, {"type": "r", "ref": 35, "children": [{"type": "t", "text": "Peijing Zhang, Li Wang, Cristian Rodriguez-Aguayo, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-205 acts as a tumour radiosensitizer by targeting ZEB1 and Ubc13."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Commun (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/ncomms6671"}], "href": "https://doi.org/10.1038/ncomms6671"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25476932"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25476932"}]}, {"type": "r", "ref": 36, "children": [{"type": "t", "text": "Xiao Yue, FengMing Lan, Man Hu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Downregulation of serum microRNA-205 as a potential diagnostic and prognostic biomarker for human glioma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Neurosurg (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3171/2015.1.JNS141577"}], "href": "https://doi.org/10.3171/2015.1.JNS141577"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26230475"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26230475"}]}, {"type": "r", "ref": 37, "children": [{"type": "t", "text": "X Sun, P Du, W Yuan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Long non-coding RNA HOTAIR regulates cyclin J via inhibition of microRNA-205 expression in bladder cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Death Dis (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/cddis.2015.269"}], "href": "https://doi.org/10.1038/cddis.2015.269"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26469956"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26469956"}]}, {"type": "r", "ref": 38, "children": [{"type": "t", "text": "Y Hu, Y Qiu, E Yagüe, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miRNA-205 targets VEGFA and FGF2 and regulates resistance to chemotherapeutics in breast cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Death Dis (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/cddis.2016.194"}], "href": "https://doi.org/10.1038/cddis.2016.194"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27362808"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27362808"}]}, {"type": "r", "ref": 39, "children": [{"type": "t", "text": "Amit Kumar Chaudhary, Goutam Mondal, Virender Kumar, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Chemosensitization and inhibition of pancreatic cancer stem cell proliferation by overexpression of microRNA-205."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Lett (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.canlet.2017.05.007"}], "href": "https://doi.org/10.1016/j.canlet.2017.05.007"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28536008"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28536008"}]}, {"type": "r", "ref": 40, "children": [{"type": "t", "text": "Wenwu Yang, Li Hong, Xuexian Xu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LncRNA GAS5 suppresses the tumorigenesis of cervical cancer by downregulating miR-196a and miR-205."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Tumour Biol (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1177/1010428317711315"}], "href": "https://doi.org/10.1177/1010428317711315"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28671039"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28671039"}]}]}]}
Synonyms MIR-205, MIRN205
NCBI Gene ID 406988
API
Download Associations
Predicted Functions View MIR205's ARCHS4 Predicted Functions.
Co-expressed Genes View MIR205's ARCHS4 Predicted Functions.
Expression in Tissues and Cell Lines View MIR205's ARCHS4 Predicted Functions.

Functional Associations

MIR205 has 981 functional associations with biological entities spanning 5 categories (molecular profile, disease, phenotype or trait, functional term, phrase or reference, cell line, cell type or tissue, gene, protein or microRNA) extracted from 21 datasets.

Click the + buttons to view associations for MIR205 from the datasets below.

If available, associations are ranked by standardized value

Dataset Summary
CCLE Cell Line Gene CNV Profiles cell lines with high or low copy number of MIR205 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset.
CCLE Cell Line Gene Expression Profiles cell lines with high or low expression of MIR205 gene relative to other cell lines from the CCLE Cell Line Gene Expression Profiles dataset.
ChEA Transcription Factor Binding Site Profiles transcription factor binding site profiles with transcription factor binding evidence at the promoter of MIR205 gene from the CHEA Transcription Factor Binding Site Profiles dataset.
ChEA Transcription Factor Targets transcription factors binding the promoter of MIR205 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset.
COSMIC Cell Line Gene CNV Profiles cell lines with high or low copy number of MIR205 gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset.
CTD Gene-Disease Associations diseases associated with MIR205 gene/protein from the curated CTD Gene-Disease Associations dataset.
ENCODE Histone Modification Site Profiles histone modification site profiles with high histone modification abundance at MIR205 gene from the ENCODE Histone Modification Site Profiles dataset.
ENCODE Transcription Factor Binding Site Profiles transcription factor binding site profiles with transcription factor binding evidence at the promoter of MIR205 gene from the ENCODE Transcription Factor Binding Site Profiles dataset.
ENCODE Transcription Factor Targets transcription factors binding the promoter of MIR205 gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset.
ESCAPE Omics Signatures of Genes and Proteins for Stem Cells PubMedIDs of publications reporting gene signatures containing MIR205 from the ESCAPE Omics Signatures of Genes and Proteins for Stem Cells dataset.
GAD Gene-Disease Associations diseases associated with MIR205 gene in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset.
GeneRIF Biological Term Annotations biological terms co-occuring with MIR205 gene in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset.
GeneSigDB Published Gene Signatures PubMedIDs of publications reporting gene signatures containing MIR205 from the GeneSigDB Published Gene Signatures dataset.
GEO Signatures of Differentially Expressed Genes for Gene Perturbations gene perturbations changing expression of MIR205 gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset.
HuGE Navigator Gene-Phenotype Associations phenotypes associated with MIR205 gene by text-mining GWAS publications from the HuGE Navigator Gene-Phenotype Associations dataset.
JASPAR Predicted Transcription Factor Targets transcription factors regulating expression of MIR205 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset.
Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles cell lines with high or low copy number of MIR205 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset.
MGI Mouse Phenotype Associations 2023 phenotypes of transgenic mice caused by MIR205 gene mutations from the MGI Mouse Phenotype Associations 2023 dataset.
MotifMap Predicted Transcription Factor Targets transcription factors regulating expression of MIR205 gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset.
MPO Gene-Phenotype Associations phenotypes of transgenic mice caused by MIR205 gene mutations from the MPO Gene-Phenotype Associations dataset.
Roadmap Epigenomics Histone Modification Site Profiles histone modification site profiles with high histone modification abundance at MIR205 gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset.